Form 4 for BHC Bausch Health Companies Inc.
Accepted 2026-08-20 16:33:42 ET · period of report 2026-08-19 · accession 0000885590-26-000109 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-20 16:33 | 2026-08-19 | BHC | Lenar Aimee J. | Pres, US Pharma | S - Sale | $7.03 | -36.8K | 334.9K | -10% | -$258.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares, No Par Value | 2026-08-19 | S | D | 36,827 | $7.03 | 334,853 | D | — | — | (F1) Represents shares of common stock sold in the open market pursuant to a Rule 10b5-l plan adopted by the Reporting Person on May 21, 2026. |